Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc.

Alico ( ($ALCO) ) just unveiled an update. Effective July 14, 2026, Alico, Inc. entered into a third amended and restated employment agreement with...

Alico Extends CEO Contract and Enhances Incentive Plan

RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Alcidion Group Limited on July 16 and set a price target of A$0.12. The company’s sh...

RBC Capital Remains a Hold on Alcidion Group Limited (ALC)

Balco Group AB ( ($SE:BALCO) ) has provided an announcement. Balco Group AB, a specialist in balcony and facade construction and renovation, primar...

Balco boosts backlog and launches efficiency drive amid financing revamp

Alcidion Group Limited ( ($AU:ALC) ) has provided an update. Alcidion has reaffirmed its full-year FY26 guidance, expecting revenue to exceed $50 m...

Alcidion Reconfirms FY26 Outlook and Closes Telstra Health Kyra Acquisition

Alcidion Group Limited ( ($AU:ALC) ) has shared an announcement. Alcidion Group Limited is a healthcare technology provider focused on digital solu...

Alcidion targets Asian investors with Singapore and Hong Kong roadshow

CalciMedica ( ($CALC) ) has issued an update. On June 23, 2026, CalciMedica entered into a securities purchase agreement for a private placement of...

CalciMedica Advances Auxora After Favorable FDA Safety Review

Analysts have been eager to weigh in on the Healthcare sector with new ratings on OnKure Therapeutics (OKUR) and CalciMedica (CALC). OnKure Therape...

Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and CalciMedica (CALC)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Nicox SA today and set a price target of €1.00. Selvaraju covers the Healthcare se...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ALC	$70.26	-0.51%	2.65M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ALC	$70.26	-0.5%	2.65M
3
4
5
6

ALC

ALC

Get Alcon Inc. Data in Excel

Get Alcon Inc. Data in Excel